Supp. Fig. 3 . Negative controls for immunostaining and confocal microscopy. Representative confocal micrographs of myoblasts differentiated for 24 h immunostained for TGN38. Primary antibodies against ATP7A or ATP7B were excluded from the mixture, and secondary antibodies were later included as a negative control.
Supplementary Figure 4
Supp. Fig. 4 . Stability of Atp7b mRNA does not change during myogenic differentiation. A. Schematic of Atp7b 3' UTR showing the presence of only one PAS. B. Atp7b mRNA in proliferating myoblasts is stable as determined by actinomycin D treatment followed by qRT-PCR. Stability of Myc mRNA was used as a positive control. C. Atp7b mRNA in differentiated myotubes is stable as determined by actinomycin D treatment followed by qRT-PCR. Stability of Myc mRNA was used as a positive control. All data represent the average of three independent biological experiments ± SE; ***P<0.001.
